Evidence map›Paper›PMID 17378589›Full record

ReviewBiochemistry2007

Delivery of retinoid-based therapies to target tissues.

Alexander R Moise, Noa Noy, Krzysztof Palczewski, William S Blaner

Open access · greenAbstract readReview
In one paragraph

Review in Biochemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Hypertension and the fat-soluble vitamins A, D and E.International journal of environmental research and public health · 2015
    Trial
  3. Review
  4. Review
  5. ZebrafishFrontiers in cell and developmental biology · 2024
    Article
  6. Review
  7. Vitamin A: too good to be bad?Frontiers in pharmacology · 2023
    Review
  8. Article
  9. Article
  10. Theoretical Study of the Photoisomerization Mechanism of All-The journal of physical chemistry. A · 2021
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Interphotoreceptor retinoid-binding protein removes all-The Journal of biological chemistry · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alexander R MoiseDepartment of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106-4965, USA. ram50@case.edu
Noa Noy
Krzysztof Palczewski
William S Blaner
Columbia University · USCase Western Reserve University · US

Funding

Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI MAUREEN E NEITZ · 1985 to 2026
$23.5M
REGULATION OF RHODOPSIN KINASE AND GUANYLATE CYCLASER01EY008061 · NEI · UNIVERSITY OF WASHINGTON · PI PALCZEWSKI, KRZYSZTOF · 1994 to 2014
$9.5M
Postprandial Vitamin AR01DK068437 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BLANER, WILLIAM S · 2004 to 2023
$7.0M
VERTEBRATE CAROTENOID ISOMERASESR03EY015399 · NEI · UNIVERSITY OF WASHINGTON · PI PALCZEWSKI, KRZYSZTOF NMI · 2004 to 2006
$454k
Postprandial Vitamin AR56DK068437 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BLANER, WILLIAM S · 2009 to 2009
$450k
RHODOPSIN KINASE: REGULATION, FUNCTION AND STRUCTURER29EY008061 · NEI · UNIVERSITY OF WASHINGTON · PI PALCZEWSKI, KRZYSZTOF NMI · 1989 to 1993
–
NEI NIH HHS EY015399NEI NIH HHS EY01730NEI NIH HHS EY08061NEI NIH HHS P30 EY001730NEI NIH HHS R01 EY008061NEI NIH HHS R03 EY015399NIDDK NIH HHS DK068437NIDDK NIH HHS R01 DK068437NIDDK NIH HHS R56 DK068437
6 · The paper itself

Abstract

Through its various metabolites, vitamin A controls essential physiological functions. Both naturally occurring metabolites and novel retinoid analogues have shown effectiveness in many clinical settings that include skin diseases and cancer, and in animal models of human conditions affecting vision. In this review, we analyze several potential retinoid-based therapies from the point of view of drug metabolism and transport to target tissues. We focus on the endogenous factors that affect the absorption, transport, and metabolism of retinoids by taking into account data obtained from the analysis of animal models that lack the enzymes or proteins involved in the storage and absorption of retinoids. We also discuss findings of toxicity associated with retinoids in an effort to improve the outcome of retinoid-based therapies. In this context, we review evidence that esterification of retinol and retinol-based drugs within target tissues provides one of the most efficient means to improve the absorption and to reduce the toxicity associated with pharmacological doses of retinoids. Future retinoid-based therapeutic strategies could involve targeted delivery mechanisms leading to lower toxicity and improved effectiveness of retinoids.

Indexed as

AnimalsHumansIntestinal AbsorptionModels, BiologicalRetinoidsRetinol-Binding ProteinsTissue DistributionRetinoidsRetinol-Binding Proteins

Identifiers

PMID17378589
PMCPMC2562735
OpenAlexW2107673143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.